Pfizer Dodges Challenge to Its Board

Pfizer proxy fight averted as Starboard stands down, for now
Activist investor won’t push for board seats, but could still agitate from the sidelines if Pfizer’s stock continues to underperform.
Pfizer Dodges Challenge to Its Board in Fight With Starboard
Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter.
Pfizer Gets Breather From Starboard’s Ongoing Assault
Starboard last year took a $1 billion stake in Pfizer, looking to turn the pharma around after alleged severe shortcomings by its current leadership. But Bloomberg reports it has missed the deadline for nominating a director to the pharma’s board.
Pfizer avoids board nominations from Starboard as proxy fight rolls on: Bloomberg
Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the activist investor’s unfolding proxy fight. | Activist Investor Starboard Value stopped short of nominating any directors to Pfizer’s board ahead of a Jan.
PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor
A Bloomberg article suggests activist investor Starboard cut Pfizer some slack by not nominating any director on the company's board this year.
Starboard did not nominate Pfizer board members, Bloomberg says
Activist Starboard Value did not nominate any directors to Pfizer’s (PFE) board ahead of a January 25 deadline for the company’s annual meeting
Pfizer CEO Says Activist Wants Minimal Changes, Plays Down Fight
Pfizer Inc.’s dispute with activist firm Starboard Value LP isn’t “an aggressive situation,” Chief Executive Officer Albert Bourla said, months after the feared investor disclosed a stake in the company and questioned his management.
Pfizer gains after activist investor forgoes board nominations
A sigh of relief among Pfizer (PFE) investors lifts shares after activist investor group Starboard Value did not nominate any directors to the pharmaceutical giant's board, according to a report from Bloomberg.
Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard — For Now
Pfizer stock bounded off its 50-day line on Monday after avoiding a battle with activist investor Starboard Value — for now.
Starboard refrains from nominating directors to Pfizer's board - Bloomberg
Pfizer Inc. (NYSE:PFE) has temporarily avoided a standoff with activist investor Starboard Value LP. According to Bloomberg sources, Starboard did not put forward any nominations for Pfizer's board before the January 25 deadline for the pharmaceutical company's annual meeting in April.
What's Going On With Pfizer Stock Monday?
Pfizer Inc (NYSE:PFE) shares are trading higher Monday. Some of the optimism may be surrounding activist Starboard Value's ...
Business Insider16d
Pfizer CEO Bourla says Starboard Value wants minimal changes, Bloomberg says
Pfizer (PFE) CEO Albert Bourla said the company’s dispute with activist firm Starboard Value isn’t “an aggressive situation,” months after the investor disclosed a stake in the company and ...
Bloomberg L.P.3d
Pfizer Dodges Challenge to Its Board in Battle With Starboard
Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter. Starboard did not nominate any directors ...